D'Andrea Carrie has filed 3 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 30000 shares of Grace Therapeutics, Inc. ($GRCE) on April 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 14, 2025 | Grace Therapeutics, Inc. | $GRCE | D'Andrea Carrie | VP Clinical Operations | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 12,087,270 | 9999.99% | 0.25% |
| May 6, 2024 | Grace Therapeutics, Inc. | $GRCE | D'Andrea Carrie | VP Clinical Operations | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |
| May 6, 2024 | Grace Therapeutics, Inc. | $GRCE | D'Andrea Carrie | VP Program Management | A | Stock Options (Right to Buy) | 19740 | $0.00 | 19,740.0000 | 9,529,123 | 9999.99% | 0.21% |